Hege Chen
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Circular RNAs in diseases 4
- Genomics, phytochemicals, and oxidative stress 2
- Ubiquitin and proteasome pathways 2
- Wnt/β-catenin signaling in development and cancer 1
-
- MicroRNA in disease regulation 5
- Co-authors
- Zhiyong Guo (3 shared papers)Douglas E. Linn (3 shared papers)Jonathan Melamed (3 shared papers)Hegang Chen (3 shared papers)Yun Qiu (3 shared papers)Xi Yang (3 shared papers)Xiangtian Kong (3 shared papers)Feng Sun (3 shared papers)
- Journals
- Cancer Research (2 papers)PLoS ONE (1 paper)Journal of Translational Medicine (1 paper)Scientific Reports (1 paper)Oncology Reports (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hege Chen
12 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 468
- Pulmonary and Respiratory Medicine 768
- Endocrinology, Diabetes and Metabolism 229
- Molecular Biology 825
- Genetics 207
Countries citing papers authored by Hege Chen
This map shows the geographic impact of Hege Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hege Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hege Chen more than expected).
Fields of papers citing papers by Hege Chen
This network shows the impact of papers produced by Hege Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hege Chen. The network helps show where Hege Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hege Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth Hit paper breakdown → | 2009 | 698 |
| 2 | 2009 | 183 | |
| 3 | 2014 | 121 | |
| 4 | 2014 | 102 | |
| 5 | 2015 | 61 | |
| 6 | 2010 | 53 | |
| 7 | 2015 | 35 | |
| 8 | 2013 | 33 | |
| 9 | 2014 | 31 | |
| 10 | 2014 | 30 | |
| 11 | 2016 | 22 | |
| 12 | 2017 | 15 |
About Hege Chen
Hege Chen is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Epidemiology and Organic Chemistry, having authored 12 papers that have together received 1.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers), Prostate Cancer Treatment and Research (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Ubiquitin and proteasome pathways (2 papers), Diverse Scientific Research in Ukraine (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper) and Free Radicals and Antioxidants (1 paper). The work is most often cited by research in Cancer Research (468 citations), Pulmonary and Respiratory Medicine (768 citations), Endocrinology, Diabetes and Metabolism (229 citations), Molecular Biology (825 citations) and Genetics (207 citations). Hege Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhiyong Guo, Douglas E. Linn, Jonathan Melamed, Hegang Chen, Yun Qiu, Xi Yang, Xiangtian Kong, Feng Sun, Richeng Jiang and Clifford G. Tepper. Their work appears in journals such as Cancer Research, PLoS ONE, Journal of Translational Medicine, Scientific Reports and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.